欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
IT/H/0736/005
药品名称
CLINIMIX
活性成分
alanine 0.0 %
arginine 0.0 %
calcium chloride dihydrate 0.0 %
glucose monohydrate 0.0 %
glycine 0.0 %
histidine 0.0 %
isoleucine 0.0 %
leucine 0.0 %
lysine hypochloride 0.0 %
magnesium chloride hexahydrate 0.0 %
methionine 0.0 %
potassium phosphate 0.0 %
proline 0.0 %
serine 0.0 %
sodium chloride 0.0 %
sodium acetate 0.0 %
threonine 0.0 %
tryptophan 0.0 %
tyrosine 0.0 %
valine 0.0 %
剂型
Solution for infusion
上市许可持有人
Baxter S.p.A. Piazzale Dell'Industria 20 00144 - Rome Italy
参考成员国 - 产品名称
Italy (IT)
互认成员国 - 产品名称
Finland (FI)
Poland (PL)
Cyprus (CY)
Czechia (CZ)
United Kingdom (Northern Ireland) (XI)
Germany (DE)
Denmark (DK)
Belgium (BE)
Netherlands (NL)
Luxembourg (LU)
Austria (AT)
France (FR)
Greece (GR)
Sweden (SE)
许可日期
2008/04/05
最近更新日期
2024/01/15
药物ATC编码
B05BA10 combinations
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final PL
|
common-pl-WS 58 Clinimix-
Date of last change:2021/09/17
Final SPC
|
common-spc WS 58 Clinimix
Date of last change:2021/09/17
Final Labelling
|
common-outer-clean
Date of last change:2020/02/17
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase